FDA Approved: MIRALAX — Original Application (Bayer HealthCare LLC.)

View source ↗

Summary

FDA approved Miralax (polyethylene glycol 3350) through its original NDA for use as an oral laxative to relieve constipation, developed by Bayer HealthCare LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation

Drugs mentioned

• MIRALAX (POLYETHYLENE GLYCOL 3350)

Snippet

ORIG AP for MIRALAX (POLYETHYLENE GLYCOL 3350)